Leading Companies in Qatar Metoprolol Market | Key Players & Insights 2026

Qatar Metoprolol Market Overview

According to 6Wresearch, the Qatar metoprolol market is witnessing steady growth, driven by the increasing prevalence of cardiovascular diseases (CVDs) and a proactive national health screening program. The market is currently fueled by a shift toward high-efficiency healthcare delivery, where the Ministry of Public Health (MoPH) encourages the adoption of high-quality generics to optimize healthcare expenditure. Furthermore, the push for "National Drug Security" has catalyzed local interest in secondary packaging and manufacturing of chronic care medications, reducing the total reliance on external shipments.

Competitive Landscape

The competitive landscape in Qatar is a strategic alliance between international research-based firms and high-capacity local logistics specialists. While global giants provide the clinical evidence and core manufacturing, Qatari firms distinguish themselves through the "last mile" of healthcare specialized cold-chain storage, local regulatory navigation, and exclusive supply contracts for the government-run healthcare sector.

Below is a list of leading players serving the Qatar Metoprolol Market:

1. AstraZeneca

The manufacturer of the originator brand Betaloc/Seloken, AstraZeneca remains the premium benchmark for quality in Qatar's private and public sectors.

2. Viatris Inc.

Formed from the merger of Mylan and Upjohn, Viatris provides a diverse portfolio of legacy and generic cardiovascular products widely utilized in Qatari primary care.

3. Ebn Sina Medical

Qatar's premier distributor, managing the supply of critical beta-blockers through an automated distribution hub that serves both HMC and retail pharmacies.

4. Qatar Pharma

The largest pharmaceutical factory in Qatar; it plays a vital role in local medicine production and is expanding its capabilities into oral solid dosages for chronic care.

5. Sun Pharmaceutical Industries Ltd.

A major provider of generic metoprolol formulations (Prolomet XL) in the Middle East, focusing on affordability and varied dosage strengths.

6. Teva Pharmaceutical Industries Ltd.

A global leader in generic medicine that supports Qatar's cost-optimization goals with a broad range of metoprolol succinate and tartrate versions.

7. Ali Bin Ali Medical

A key division of a major Qatari conglomerate, providing world-class supply chain solutions for international cardiovascular pharmaceutical brands.

8. Hikma Pharmaceuticals PLC

Leverages extensive regional manufacturing to supply high-demand chronic medications to the Gulf markets, including Qatar.

9. Aurobindo Pharma Limited

Supplies high-volume generic metoprolol capsules and tablets, contributing to the diversity and competitive pricing of the local market.

10. QLife Pharma

A key local manufacturer focused on enhancing Qatar's pharmaceutical self-sufficiency by producing essential generic medicines.

11. Ibn Al-Haytham Medical Co.

A prominent medical supplier specialized in the registration and multi-channel distribution of international drugs within the State of Qatar.

12. Zydus Lifesciences Limited

Noted for its diverse cardiovascular portfolio, Zydus provides multiple metoprolol dosage forms for precise patient titration in the region.

13. Dr. Reddy's Laboratories

A global generic giant that supplies high-purity metoprolol succinate to Qatar, emphasizing clinical bioequivalence and patient safety.

14. Lupin Limited

A significant player in the Middle Eastern neurology and cardiology segments, offering approved generic versions of beta-blockers.

15. Care n Cure Pharmacy

Operates one of Qatar's largest retail pharmacy chains, ensuring the 24/7 availability of metoprolol for heart disease patients nationwide